Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

S1P in Tumor Microenvironment and Modulation of Anti-Tumor-Directed T-Cell Responses.

Cells·2026
Same author

TCRcloud: a global visualization tool for T-cell and B-cell receptor transcripts.

Journal of translational medicine·2026
Same author

Computational modelling and network medicine in drug toxicology and clinical pharmacovigilance.

Journal of translational medicine·2026
Same author

Regulation of PD-L1 Protein Expression by the E3 Ubiquitin Ligase GP78.

Current issues in molecular biology·2025
Same author

Inter-Relationship Between Melanoma Vemurafenib Tolerance Thresholds and Metabolic Pathway Choice.

Cells·2025
Same author

Relationship between melanoma vemurafenib tolerance thresholds and metabolic pathway choice and Wnt signaling involvement.

bioRxiv : the preprint server for biology·2025
Same journal

Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

Molecular Basis of Disease Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

General Subjects Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

Erratum to 'on the role of exchangeable hydrogen bonds for the kinetics of P680<sup>+·</sup> Q<sub>A</sub> <sup>-·</sup> formation and P680<sup>+·</sup> Pheo<sup>-·</sup> recombination in photosystem II' [Biochim. Biophys. Acta 1276 (1996) 35-44].

Biochimica et biophysica acta·2019
Same journal

Oligomeric state of the light-harvesting complexes B800-850 and B875 from purple bacterium Rubrivivax gelatinosus in detergent solution.

Biochimica et biophysica acta·2019
Same journal

Regulation of pigment content and enzyme activity in the cyanobacterium Nostoc sp. Mac grown in continuous light, a light-dark photoperiod, or darkness.

Biochimica et biophysica acta·2019
See all related articles

Related Experiment Video

Updated: Jun 11, 2026

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on: July 12, 2018

Galectin-3: A novel substrate for c-Abl kinase.

Vitaly Balan1, Pratima Nangia-Makker, Young Suk Jung

  • 1Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA. vitaly.balan@gmail.com

Biochimica Et Biophysica Acta
|July 6, 2010
PubMed
Summary
This summary is machine-generated.

Researchers identified novel tyrosine phosphorylation sites on galectin-3, a key protein in cell interactions. The c-Abl kinase phosphorylates galectin-3 at Tyr107, impacting cell morphology and motility.

More Related Videos

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on: October 17, 2025

Related Experiment Videos

Last Updated: Jun 11, 2026

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on: July 12, 2018

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on: October 17, 2025

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Galectin-3 is a beta-galactoside-binding lectin with diverse cellular functions, including roles in cell growth, adhesion, and interaction.
  • Its biological activity, particularly its pro- or anti-apoptotic effects, is influenced by cellular localization and post-translational modifications like cleavage and phosphorylation.
  • Phosphorylation of galectin-3 is known to modulate its sugar-binding capabilities.

Purpose of the Study:

  • To identify novel tyrosine phosphorylation sites on galectin-3.
  • To determine the specific kinase responsible for phosphorylating these sites.
  • To investigate the functional consequences of galectin-3 phosphorylation at identified sites.

Main Methods:

  • In vitro and in vivo phosphorylation assays were performed to identify and confirm tyrosine phosphorylation sites on galectin-3.
  • Mass spectrometry was utilized to pinpoint specific tyrosine residues targeted for phosphorylation.
  • The kinase activity of c-Abl was assessed in relation to galectin-3 phosphorylation.
  • Galectin-3 null SK-Br-3 cells were used to express wild-type and mutant galectin-3 (Y107F) for functional studies.

Main Results:

  • Novel tyrosine phosphorylation sites were identified at positions 79, 107, and 118 of galectin-3.
  • The c-Abl kinase was identified as the responsible kinase for phosphorylating these tyrosine residues.
  • Tyrosine 107 was determined to be the primary phosphorylation target of c-Abl on galectin-3.
  • Expression of a galectin-3 Y107F mutant in galectin-3 null cells resulted in altered cell morphology and increased motility compared to cells expressing wild-type galectin-3.

Conclusions:

  • The study identified c-Abl as a novel kinase that phosphorylates galectin-3 at specific tyrosine residues (79, 107, 118), with Tyr107 being a major site.
  • Phosphorylation of galectin-3, particularly at Tyr107, influences cellular morphology and motility.
  • Further research is warranted to fully elucidate the functional significance of these novel phosphorylation events in galectin-3 biology.